XORTX Therapeutics Inc. (XRTX) stock
XRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.06+0.02 (+1.92%)
Close on Nov 17, 2026Market cap $116.17KP/E –Yield –
XORTX Therapeutics cash
Cash and short-term investments held at the end of each period.
XORTX Therapeutics's cash was C$18.85M at Dec 31, 2021. For fiscal 2021 it was C$18.85M, up 10906.7% from the year before.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | C$18.85M | +10906.7% |
| FY2020 | Dec 31, 2020 | C$171.27K | +192.2% |
| FY2019 | Dec 31, 2019 | C$58.61K | -77.5% |
| FY2018 | Dec 31, 2018 | C$260.02K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2021 | Dec 31, 2021 | C$18.85M | – |
| Q4 FY2020 | Dec 31, 2020 | C$171.27K | – |
| Q4 FY2019 | Dec 31, 2019 | C$58.61K | – |
| Q4 FY2018 | Dec 31, 2018 | C$260.02K | – |
See a number that looks wrong?